You and I should get together for 6am coffee, Ovi . . . we
You and I should get together for 6am coffee, Ovi . . . we are the only one's that post this early! I think you can get "grumpy" about your investments when it becomes "emotional". You and I and other "long-termer's" were lucky to get into CTIX early and make money. I see from some posters on iFlub that they have significant funds in CTIX . . . some who have and will be hurt if this doesn't come to fruition.
My investment philosophy has changed... I am much more atune to what big investors and hedge funds are doing and following them. They are much smarter than me.Yes, I am a fan of the Baker Bros and several others. If you looked at MACK (not a Baker holding) the last quarter you would have seen massive hedge fund buyers, I think three that took stakes of 15 million plus shares. CTIX has been at enough conferences in the last year to have seen something...anything from institutional investors. We were fortunate (lucky) to get into CTIX in the 50 cent area and ride it to $2 plus.... but what next? I look at a company like IMUC, "news" (wishful thinking) artificially pumps it up and then it crashes....lots of people pumping it (like CTIX) but no institutional investors. If we see some real news on Kevetrtin, I will be back in. Yes, I may miss a bit of the initial bump, but that's okay. Its like my ACAD investment.... I first learned of ACAD in Sept 2013 when it was trading at $2.50....I didn't buy in until it hit $6.50.....I have been riding (and adding) and now it is $23 plus. Just what I am doing.... not saying this is a strategy for others.
Best wishes,
Jeff
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Green Wave in the Baltic It looks like MacGregor's betting big on the future of maritime transport, and they're putting their chips down on TT-Line's next-gen battery-hybrid LNG ferries. With a contract fresh out of the oven, they've signed up to kit out these eco-warriors with a range of RoRo equipment. And let me tell you, this is no piddly order—by any stretch,...
Continue Reading
Business stepping up to bat for justice reform? Yeah, that’s what's shaking over in Washington, D.C. this Constitution Day. We're seeing a gathering of senior business execs, policymakers, and public safety advocates, intent on driving judicial reform in the U.S. Usually, the suits in these rooms talk about profit margins and quarterly results, but this time they're...
Continue Reading
From Beachfront Beginnings to Global Fitness Leader Picture this: It's 1992, and Suzelle Snowden has an audacious idea. Teaching fitness classes at resorts in exchange for accommodations. Fast-forward three decades, and now, her brainchild, Fit Bodies, Inc., isn't just a wellness travel company; it's a behemoth, partnering with Hyatt's premier resorts across Mexico, the...
Continue Reading
Shareholder Investigation Shakes Things Up Like a surprise punch straight outta nowhere, Arlo Technologies, Inc. (NYSE: ARLO) finds itself under the magnifying glass of Levi & Korsinsky, LLP. They're sniffing around for possible breaches of fiduciary duties by ARLO's officers and directors. It’s a jolting call for shareholders, who need to stay sharp and not get caught...
Continue Reading
Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...
Continue Reading
The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...
Continue Reading
Hormel Foods Takes the Stage at Barclays When it comes to branded food, few players can command attention quite like Hormel Foods Corporation. They're set to make a splash at the upcoming 2026 Barclays Global Consumer Staples Conference. On September 9, Jeff Ettinger, interim CEO, and John Ghingo, the CEO-elect, will lead a fireside chat at 1:30 p.m. ET. They're not just...
Continue Reading
Choosing Your Slice of Paradise in Hilton Head Picture this—not just a sandy paradise for vacationing, but a hotspot for second-home buyers weighing their options like they're sizing up their next big investment. Enter Hilton Head, S.C., a place where strategic move means scooping up properties that marry lifestyle with fiscal savvy. Sizing Up the Dream: More Than Just...
Continue Reading
Legal Storm Brews for Soleno's Execs When you see Kuehn Law stepping into the ring, you know someone’s ruffling feathers. And this time, the target is Soleno Therapeutics (NASDAQ:SLNO), a name that might ring bells for tech folks dabbling in biotech. They’re under the spotlight because a federal securities lawsuit claims a questionable playbook was in the shuffle....
Continue Reading
High-Caliber Recruits Steer Hycroft's Ambitious Path Hycroft Mining's move to bulk up its board ought to raise eyebrows across the mining landscape. By snagging some of the biggest names in the industry, they're not just shuffling the deck—they're bringing in a whole new game plan. If you're tracking NASDAQ:HYMC, this is news you don't brush off. The New Power Quartet...
Continue Reading
Top 5 Most Recently Viewed Articles
Class Action Notice for Inspire Medical Systems, Inc. Attention shareholders! The Gross Law Firm has issued an important message concerning Inspire Medical Systems, Inc. (NYSE: INSP). This notice is particularly relevant for those who purchased shares within the designated class action period. If you are an investor in INSP, it is vital to understand the implications of...
Continue Reading
Illumina's Financial Results Overview Illumina, Inc. (Nasdaq: ILMN) has recently presented its financial results for the third quarter of fiscal year 2025. The company reported a revenue of $1.08 billion, indicating stability as it remained flat compared to the same quarter in the previous year, both on a reported and constant currency basis. Notably, the GAAP diluted...
Continue Reading
Azitra's Upcoming Presentation at Prominent Forum Azitra, Inc. (NYSE American: AZTR), a biopharmaceutical company dedicated to precision dermatology, is set to have its Chief Operating Officer, Travis Whitfill, Ph.D., MPH, present groundbreaking research at the Microbiome Times Partnering Forum. This esteemed event, known for attracting key industry players, will take...
Continue Reading
Safe Pro Group Advances with New Provisional Patent Safe Pro Group Inc. (Nasdaq: SPAI) is on the cutting edge of innovation with a recent provisional patent application filed for leveraging drones and artificial intelligence (AI) in enhancing object detection precision. This comes as a significant step for the company, dedicated to providing high-quality AI solutions,...
Continue Reading
Revolutionizing Cash and Crypto Transactions MoneyGram has announced a powerful new tool, MoneyGram Ramps, designed specifically for developers looking to connect cash and cryptocurrency seamlessly. This innovative API allows for quick and compliant cash-to-crypto and crypto-to-cash integrations, changing the way digital financial transactions occur worldwide. The Easiest...
Continue Reading